Yaxi Chen - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Yaxi Chen

Showing results (121-130 of 126) with videos related to

Pageof 13

Sort By:

You have reached the last page of results.This site can display upto 126 results.

JAMA Oncology|October 5, 2023

Tislelizumab vs Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Phase 3 Randomized Clinical TrialShukui Qin, Masatoshi Kudo, Tim Meyer, et al.

Nature Communications|October 2, 2022

CD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasisPing Yang, Hong Qin, Yiyu Li, et al.

JTCVS Open|November 13, 2024

Improving prediction accuracy of spread through air spaces in clinical-stage T1N0 lung adenocarcinoma using computed tomography imaging modelsShihua Dou, Zhuofeng Li, Zhenbin Qiu, et al.

Experimental Eye Research|July 25, 2025

Characterization of optic nerve regeneration following Nd:YAG laser-induced injury in Xenopus tropicalisJunkai Tan, Chumou Liu, Yaxi Chen, et al.

BMJ Oncology|February 25, 2026

SAFFRON-301: a randomised phase III study of sitravatinib in combination with tislelizumab in patients with locally advanced or metastatic non-small cell lung cancerQing Zhou, Bo Gao, Jie Hu, et al.

Journal of Hepatology|April 30, 2018

CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitisLei Zhao, Chang Zhang, Xiaoxiao Luo, et al.

Pageof 13

Search research articles

Showing results (121-130 of 126) with videos related to

Sort By:

Pageof 13

You have reached the last page of results.This site can display upto 126 results.

JAMA Oncology|October 5, 2023

Tislelizumab vs Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Phase 3 Randomized Clinical TrialShukui Qin, Masatoshi Kudo, Tim Meyer, et al.

Nature Communications|October 2, 2022

CD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasisPing Yang, Hong Qin, Yiyu Li, et al.

JTCVS Open|November 13, 2024

Improving prediction accuracy of spread through air spaces in clinical-stage T1N0 lung adenocarcinoma using computed tomography imaging modelsShihua Dou, Zhuofeng Li, Zhenbin Qiu, et al.

Experimental Eye Research|July 25, 2025

Characterization of optic nerve regeneration following Nd:YAG laser-induced injury in Xenopus tropicalisJunkai Tan, Chumou Liu, Yaxi Chen, et al.

BMJ Oncology|February 25, 2026

SAFFRON-301: a randomised phase III study of sitravatinib in combination with tislelizumab in patients with locally advanced or metastatic non-small cell lung cancerQing Zhou, Bo Gao, Jie Hu, et al.

Journal of Hepatology|April 30, 2018

CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitisLei Zhao, Chang Zhang, Xiaoxiao Luo, et al.

Pageof 13